ABOS Acumen Pharma Projected Future Earnings
Acumen Pharmaceuticals (ABOS) attracts leading biochemists with its academic environment and R&D potential to combat Alzheimer's disease. In GURU.Markets, the analytical assessment of future profits includes dynamics where the value of expresses the metric level. Acumen Pharmaceuticals is implementing algorithms and substance synthesis automation, although physicians oversee the tests. Current clinical trials are creating negative operating leverage due to rising laboratory costs.
Metric breakdowns and analytics for Acumen Pharmaceuticals, Inc (ABOS)
- share price and consensus valuation forecast:
- market capitalization data:
- book capitalization indicators:
- company liabilities and liquidity data:
Total Debt to Capital Acumen Pharmaceuticals|ABOS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Acumen Pharmaceuticals, Inc.|ABOS - Company Aggregate Debt|Debt to Book Value Acumen Pharma|ABOS - Company Long-Term Loans and Borrowings|Company Short-Term Debt Acumen Pharmaceuticals|Quick Ratio acumenpharm.com
- earnings and market ratios statistics:
ABOS - Final Profit|Projected Future Earnings Acumen Pharmaceuticals|ABOS - P/E Multiple|Future Price to Earnings Acumen Pharma|ABOS - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Acumen Pharma|ABOS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Acumen Pharmaceuticals|ABOS - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth acumenpharm.com|ABOS - Net earnings per share growth this year|Earnings growth forecast for next year Acumen Pharmaceuticals
- revenue and sales proceeds data:
General company analysis:Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals management focuses on high-precision research into Alzheimer's disease therapies. Analyzing the organization's future profitability allows for tracking the dynamics of consensus earnings forecasts between infrequent financial reports. The indicator aggregates market expectations, identifying deviations of real value from calculated revenue growth rates. A smoothed curve may signal an artificial stabilization of quotes. A rising trend confirms the asset's fundamental potential for a long-term portfolio.
Competitor analysis for Acumen Pharmaceuticals
BIIB (Biogen) - Projected Future Earnings|Net Profit Forecast NBIX (Neurocrine Biosciences, Inc.)|Projected Future Earnings RGC|Axsome Corp - Net Profit Forecast|Projected Future Earnings ACAD (ACADIA Corp)|XENE: Net Profit Forecast|Viking Therapeutics Inc - Projected Future Earnings|Expected Net Profit Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Expected Profit|DNLI (Denali Therapeutics Inc) - Expected Profit|Expected Profit Harmony Biosciences Holdings, Inc.|Expected Profit BHVN|Future Profit AMLX (Amylyx Pharmaceuticals, Inc.)|Future Net Profit TRVI|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Expected Profit|CBLL: Future Profit|Expected Net Income PRTA (prothena.com)|Alector, Inc. (ALEC) - Expected Profit|Net Profit Forecast ANNX|Expected Profit Omeros Corp.|Neurogene Therapeutics (NGNE) - Company Profit Forecast|Projected Future Earnings ACIU|VYGR (Voyager Therapeutics) - Expected Net Income|Projected Future Earnings NMRA (neumoratx.com)|SCLX: Net Profit Forecast|TVGN - Expected Profit|Expected Net Profit Alpha Cognition Inc.|CGTX: Projected Future Earnings|inhibikase.com (IKT) - Projected Future Earnings|Expected Profit Cassava Sciences Inc|ASRT - Projected Net Profit|Expected Profit Coya (COYA)|Projected Future Earnings VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Future Profit|CRVO: Net Profit Forecast|Alterity Therapeutics Ltd. - Projected Future Earnings|Expected Net Profit clene.com|pepgen.com (PEPG) - Expected Profit|Expected Net Profit Jupiter Neurosciences, Inc. (JUNS)|Expected Profit Relmada Therapeutics|Net Profit Forecast ANVS (Annovis Bio, Inc.)|Projected Future Earnings GRCE|Company Profit Forecast Firefly Neuroscience, Inc.|Expected Profit anewmeds.com KLTO|Company Profit Forecast NeuroSense Therapeutics (NRSN)|RVPH: Future Profit|MTVA - Projected Future Earnings|NRXS (neuraxis.com) - Future Profit|Expected Net Profit Helius Medical Technologies Inc. (HSDT)|Expected Profit Passage Bio Corp|Future Profit Neuphoria Therapeutics (NEUP)|Projected Future Earnings NERV|ATHA - Expected Net Profit|Projected Future Earnings ADXN (addextherapeutics.com)|Alzamend (ALZN) - Expected Net Profit|CYCN: Future Profit|Expected Net Profit Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Expected Profit|Expected Net Profit Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Projected Future Earnings|BCLI (Brainstorm Cell Therapeutics Inc.) - Future Net Profit|Projected Future Earnings CARA|CHRO - Expected Net Profit|Eliem Therapeutics - Future Profit|Intra-Cellular (ITCI) - Expected Net Profit|LBPH - Expected Profit|MRNS - Projected Future Earnings|NKGN: Projected Future Earnings|NeuroBo Pharma (NRBO) - Projected Future Earnings|Future Profit SAGE|Net Profit Forecast SNPX (Synaptogenix, Inc.)|Expected Profit Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Expected Net Income|Expected Profit Anew Medical WENA|Future Net Profit CERE (Cerevel)
